Effects of Tinospora cordifolia (giloy) on metabolic syndrome components: a mechanistic review
- PMID: 39731594
- DOI: 10.1007/s00210-024-03642-2
Effects of Tinospora cordifolia (giloy) on metabolic syndrome components: a mechanistic review
Abstract
Metabolic syndrome is a cluster of some conditions such as high blood sugar, high blood triglycerides, low HDL cholesterol, abdominal obesity, and high blood pressure. Introducing a drug or a food that manages the majority of these medical conditions is invaluable. Tinospora cordifolia, known as guduchi and giloy, is a medicinal herb in ayurvedic medicine that is used in the treatment of various diseased conditions and also as a food for the maintenance of health. Here, we reviewed the current evidence supporting the role of giloy in the development and treatment of metabolic syndrome components. Appropriate articles that have been published until May 2024 were carefully extracted from PubMed, Scopus, and WOS databases to write a narrative review systematically. Gathered data showed the beneficial effects of giloy on metabolic syndrome components: hyperlipidemia, obesity, atherosclerosis, hypertension, and especially diabetes mellitus. As diabetes and insulin resistance seem to be a central feature of metabolic syndrome and in turn, can cause dyslipidemia, obesity, and, atherosclerosis, these beneficial effects are predictable with the anti-diabetogenic property of giloy. In this review, the main mechanisms of action of giloy in metabolic syndrome components are discussed. Based on the results, although giloy has been less investigated, considerable studies provide evidence of its beneficial effects on different components of metabolic syndrome. Relevant clinical trials are necessary to validate the mentioned effects, safety, and optimum dose of this herbal medicine and its components in managing different components of metabolic syndrome and transition from bench to bedside.
Keywords: Diabetes; Guduchi; Hyperlipidemia; Hypertension; Metabolic syndrome; Obesity.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests and also H.H. is the Editor of Naunyn-Schmiedebergs Arch Pharmacol and followed the submission guidelines of the journal ( https://link.springer.com/journal/210/submission-guidelines#Instructions%20for%20Authors_Competing%20Interests ).
References
-
- Ahmad N, Nawab M, Kazmi MH, Fatima SH (2021) Evaluation of efficacy and safety of a polyherbal unani formulation in diabetes mellitus type 2 (Zayābīṭus sukkari qism sāni)-a randomised controlled clinical study. Indian J Tradit Knowl 20(1):15–20
-
- Ahsan R, Mishra A, Badar B, Owais M, Mishra V (2023) Therapeutic application, phytoactives and pharmacology of tinospora cordifolia: an evocative review. Chin J Integr Med 29(6):549–555. https://doi.org/10.1007/s11655-023-3733-2 - DOI - PubMed - PMC
-
- Akaberi M, Hosseinzadeh H (2016) Grapes (Vitis vinifera) as a potential candidate for the therapy of the metabolic syndrome. Phytother Res 30(4):540–556. https://doi.org/10.1002/ptr.5570 - DOI - PubMed
-
- Ambalavanan R, John AD, Selvaraj AD (2020) Nano-encapsulated Tinospora cordifolia (Willd.) using poly (D, L-lactide) nanoparticles educe effective control in streptozotocin-induced type 2 diabetic rats. IET Nanobiotechnol 14(9):803–808. https://doi.org/10.1049/iet-nbt.2020.0085 - DOI - PubMed - PMC
-
- Aminifard T, Razavi BM, Hosseinzadeh H (2021) The effects of ginseng on the metabolic syndrome: an updated review. Food Sci Nutr 9(9):5293–5311. https://doi.org/10.1002/fsn3.2475 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
